# Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)

> **NCT02719184** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 463 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive
- Pulmonary Emphysema

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02719184
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-13
- **Primary completion:** 2021-06-14
- **Final completion:** 2021-06-14
- **Target enrollment:** 463 (ACTUAL)
- **Last updated:** 2024-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02719184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02719184, "Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02719184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*